Výsledky vyhledávání - Hiromitsu Kumada
- Zobrazuji výsledky 1 - 20 z 68
- Přejít na další stránku
-
1
-
2
-
3
Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the cox proportional hazard model Autor Kenji Ikeda, Hiromitsu Kumada, Satoshi Saitoh, Yasuji Arase, Kazuaki Chayama
Vydáno 1991Artigo -
4
-
5
Efficacy of nalfurafine hydrochloride in patients with chronic liver disease with refractory pruritus: A randomized, double‐blind trial Autor Hiromitsu Kumada, Hiroshi Miyakawa, Taro Muramatsu, Naoki Ando, Takanori Oh, Kenji Takamori, Hidetomo Nakamoto
Vydáno 2016Artigo -
6
Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses Autor Toshiyuki Tamai, Seiichi Hayato, Seiichiro Hojo, Takuya Suzuki, Takuji Okusaka, Kenji Ikeda, Hiromitsu Kumada
Vydáno 2017Artigo -
7
-
8
Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study Autor Ryosuke Tateishi, Takeshi Okanoue, Naoto Fujiwara, Kiwamu Okita, Kendo Kiyosawa, Masao Omata, Hiromitsu Kumada, Norio Hayashi, Kazuhiko Koike
Vydáno 2014Artigo -
9
-
10
Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis Autor Masahiro Kobayashi, Kenji Ikeda, Satoshi Saitoh, Fumitaka Suzuki, Akihito Tsubota, Yoshiyuki Suzuki, Yasuji Arase, N Murashima, Kazuaki Chayama, Hiromitsu Kumada
Vydáno 2000Artigo -
11
Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor—A prospective randomized study of hepatitis C virus–relate... Autor Kenji Ikeda, Yasuji Arase, Satoshi Saitoh, Masahiro Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Akihito Tsubota, Kazuaki Chayama, Naoya Murashima, Hiromitsu Kumada
Vydáno 2000Artigo -
12
Randomized trial of interferon‐ and ribavirin‐free ombitasvir/paritaprevir/ritonavir in treatment‐experienced hepatitis C virus–infected patients Autor Kazuaki Chayama, Kazuo Notsumata, Masayuki Kurosaki, Ken Sato, Lino Rodrigues, Carolyn M. Setze, Prajakta Badri, Edward Tam, Regis A. Vilchez, Hiromitsu Kumada
Vydáno 2015Artigo -
13
Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients Autor Akihiro Matsumoto, Eiji Tanaka, Akinori Rokuhara, Kendo Kiyosawa, Hiromitsu Kumada, Masao Omata, Kiwamu Okita, Norio Hayashi, Takeshi Okanoue, Shiro Iino, Kyuichi Tanikawa
Vydáno 2005Artigo -
14
Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis Autor Masahiro Kobayashi, Kenji Ikeda, Tetsuya Hosaka, Hitomi Sezaki, Takashi Someya, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Hiromitsu Kumada
Vydáno 2005Artigo -
15
ITPA Polymorphism Affects Ribavirin-Induced Anemia and Outcomes of Therapy—A Genome-Wide Study of Japanese HCV Virus Patients Autor Hidenori Ochi, T Maekawa, Hiromi Abe, Yasufumi Hayashida, Rikita Nakano, Michaki Kubo, Tatsuhiko Tsunoda, C. Nelson Hayes, Hiromitsu Kumada, Yusuke Nakamura, Kazuaki Chayama
Vydáno 2010Artigo -
16
Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus Autor Kenji Ikeda, Satoshi Saitoh, Yoshiyuki Suzuki, Masahiro Kobayashi, Akihito Tsubota, Mizuho Fukuda, Isao Koida, Yasuji Arase, Kazuaki Chayama, N Murashima, Hiromitsu Kumada
Vydáno 1998Artigo -
17
High serum des‐gamma‐carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma Autor Masahiro Kobayashi, Kenji Ikeda, Yusuke Kawamura, Hiromi Yatsuji, Tetsuya Hosaka, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Hiromitsu Kumada
Vydáno 2009Artigo -
18
Effect of Interferon Therapy on Hepatocellular Carcinogenesis in Patients With Chronic Hepatitis Type C: A Long–Term Observation Study of 1,643 Patients Using Statistical Bias Corr... Autor Kenji Ikeda, Satoshi Saitoh, Yasuji Arase, Kazuaki Chayama, Yoshiyuki Suzuki, Masahiro Kobayashi, Akihito Tsubota, Mizuho Kobayashi, Ikuo Nakamura, Naoya Murashima, Hiromitsu Kumada, Masahiro Kawanishi
Vydáno 1999Artigo -
19
Glomerulonephritis in Autopsy Cases with Hepatitis C Virus Infection. Autor Yasuji Arase, Kenji Ikeda, Naoya Murashima, Kazuaki Chayama, Akihito Tsubota, Isao Koida, Yoshiyuki Suzuki, Satoshi Saitoh, Masahiro Kobayashi, Mariko Kobayashi, Mizuho Kobayashi, Hiromitsu Kumada
Vydáno 1998Artigo -
20
Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B Autor Yasuji Arase, Kenji Ikeda, Fumitaka Suzuki, Yoshiyuki Suzuki, Satoshi Saitoh, Masahiro Kobayashi, Norio Akuta, Takashi Someya, Tetsuya Hosaka, Hitomi Sezaki, Mariko Kobayashi, Hiromitsu Kumada
Vydáno 2006Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Gastroenterology
Hepatocellular carcinoma
Virus
Biology
Hepatitis C virus
Immunology
Cirrhosis
Virology
Gene
Oncology
Ribavirin
Genetics
Hepatitis C
Confidence interval
Hepatology
Hazard ratio
Hepatitis B virus
Pathology
Physics
Genotype
Adverse effect
Cancer research
Hepatitis B
Incidence (geometry)
Lenvatinib
Optics
Proportional hazards model
Sorafenib